Trials / Conditions / AFP Gastric or Gastroesophageal Junction Adenocarcinoma
AFP Gastric or Gastroesophageal Junction Adenocarcinoma
3 registered clinical trials studyying AFP Gastric or Gastroesophageal Junction Adenocarcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/ NCT07515625 | Fudan University | Phase 2 |
| Recruiting | Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced NCT07289997 | Hebei Medical University Fourth Hospital | Phase 2 |
| Not Yet Recruiting | Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junc NCT06973330 | Anhui Provincial Cancer Hospital | Phase 2 |